Prospective evaluation of 3-T MRI performed before initial transrectal ultrasound-guided prostate biopsy in patients with high prostate-specific antigen and no previous biopsy.
about
Prostate Radiotherapy in the Era of Advanced Imaging and Precision MedicineRole of multiparametric magnetic resonance imaging in early detection of prostate cancerThe role of magnetic resonance imaging in the diagnosis and management of prostate cancerCurrent status of magnetic resonance imaging (MRI) and ultrasonography fusion software platforms for guidance of prostate biopsiesMultiparametric MRI in biopsy guidance for prostate cancer: fusion-guidedTargeted prostate biopsy: value of multiparametric magnetic resonance imaging in detection of localized cancerMultiparametric MRI followed by targeted prostate biopsy for men with suspected prostate cancer: a clinical decision analysisCombination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients.A critical comparison of techniques for MRI-targeted biopsy of the prostate.Standards for prostate biopsy.Diagnosis of relevant prostate cancer using supplementary cores from magnetic resonance imaging-prompted areas following multiple failed biopsies.Focal therapy for prostate cancer: The current status.Prostate cancer detection rates of magnetic resonance imaging-guided prostate biopsy related to Prostate Imaging Reporting and Data System score.Prevalence and Risk Factors of Prostate Cancer in Chinese Men with PSA 4-10 ng/mL Who Underwent TRUS-Guided Prostate Biopsy: The Utilization of PAMD ScoreEvidence-based guideline recommendations on multiparametric magnetic resonance imaging in the diagnosis of prostate cancer: A Cancer Care Ontario clinical practice guidelineInvestigating the ability of multiparametric MRI to exclude significant prostate cancer prior to transperineal biopsy.Imaging and Markers as Novel Diagnostic Tools in Detecting Insignificant Prostate Cancer: A Critical OverviewMRI-targeted prostate biopsy: a review of technique and results.Multiparametric magnetic resonance imaging in the management and diagnosis of prostate cancer: current applications and strategies.Optimization of prostate biopsy: review of technique and complications.Comparison of image-guided targeted biopsies versus systematic randomized biopsies in the detection of prostate cancer: a systematic literature review of well-designed studies.Multiparametric MRI-targeted TRUS prostate biopsies using visual registration.Recent advances in image-guided targeted prostate biopsy.Magnetic resonance imaging-guided prostate biopsy: present and futureOptimizing Patient Population for MP-MRI and Fusion Biopsy for Prostate Cancer Detection.Evaluating the Role of mpMRI in Prostate Cancer Assessment.Role of PI-RADSv2 with multiparametric MRI in determining who needs active surveillance or definitive treatment according to PRIAS.Role of multiparametric magnetic resonance imaging in the diagnosis of prostate cancer.Co-registration of MRI and ultrasound: accuracy of targeting based on radiology-pathology correlationCould Magnetic Resonance Imaging Help to Identify the Presence of Prostate Cancer Before Initial Biopsy? The Development of Nomogram Predicting the Outcomes of Prostate Biopsy in the Chinese Population.PSMA as a target for radiolabelled small molecules.Spatial Tracking of Targeted Prostate Biopsy Locations: Moving Towards Effective Focal Partial Prostate Gland Ablation with Improved Treatment Planning.Magnetic resonance imaging in the early detection of prostate cancer and review of the literature on magnetic resonance imaging-stratified clinical pathways.The Current State of MR Imaging-targeted Biopsy Techniques for Detection of Prostate Cancer.Generation and characterization of nanobodies targeting PSMA for molecular imaging of prostate cancer.Comparison of re-biopsy with preceded MRI and re-biopsy without preceded MRI in patients with previous negative biopsy and persistently high PSA.Cancer detection rate of prebiopsy MRI with subsequent systematic and targeted biopsy are superior to non-targeting systematic biopsy without MRI in biopsy naïve patients: a retrospective cohort study.Cognitive-Targeted versus Magnetic Resonance Imaging-Guided Prostate Biopsy in Prostate Cancer Detection.
P2860
Q26749961-540330DC-C6E8-43BD-80AA-FA8104A8CB78Q26768765-A5F86541-3402-4573-9465-BD29F4595333Q26849794-BA5628D5-224D-4B14-B413-CF90CFC757D7Q27001055-BF811E8D-0B47-494C-B315-C8688940FECBQ27010554-DA21C39B-505F-4D1A-A965-4D21466FEA6EQ27027567-E08FB88A-C403-4E9F-AA05-BB3B1BF40EAFQ28657778-C9F20A41-6E5B-4AE0-B69C-3362201382E4Q31051724-B077F4F0-B3A9-4DE7-83EE-524E1B79D1ACQ33890165-00BF0C77-0AEF-4925-951A-57B25476F742Q34079923-F34504A8-ED86-4285-8F28-8B220A743C0DQ34678985-A9255360-3851-4215-AFDF-0AA5A851117BQ35827748-756A681E-E069-44ED-B1C8-274C2229ACFEQ36049175-48DB11F8-22E3-4DE5-88EC-98D17ED9DCEEQ36236472-76980A04-5C97-44A0-A0B2-24779DA8F468Q36271105-D8E4F0AF-CD94-481E-95EE-AC20AFE4D7A7Q36449937-71D0F7A2-3945-4ED9-90D0-FF97A8F5EA4BQ36979944-40AC7666-9D04-48A6-AE0A-A347CB7D1F52Q38141793-E64B5DF6-6C8E-46AB-A9D0-B11416580428Q38178850-87A6792D-DBC5-4DFC-885B-FC1F3A9A5E84Q38203986-A15F3A5C-DC9F-46F2-9E08-C528C9F99808Q38219598-C95DA442-E939-4980-B83F-E8A732783079Q38294506-D010EF3F-6250-4A42-A55C-04C840BF44D4Q38321884-716564ED-07AB-4071-9088-5593488B49A4Q38322905-609F69F4-0984-45C4-B933-89F8E1D352A7Q38524498-E2766DC6-5F25-4799-BB8B-B0C16D0DBA70Q38675322-7CDDA7BE-70A2-4AB5-B183-B163C5CDB0E9Q39247844-E4FF90ED-8D44-487F-9E3D-A421BADED967Q39271404-AF8483DA-7000-45BC-A005-385E4D600CE6Q39446394-2E91CEDA-F287-47C0-A5C0-7FACAF768C82Q39554008-48C5A325-E222-462F-828C-C6D7F9A1348FQ43177005-F0D37C04-11BE-45C8-A042-BAE6CC8A8F60Q47289972-7CBDB15D-6EB3-47FD-AF23-EEB8FF750664Q47949163-9818ADAB-742D-4F40-9D76-D1F4CE092FBBQ50088856-F69EF929-C60B-4454-ADD2-67E185342725Q51743830-ACA39FDC-E2D1-4796-B9CF-6C90D62465A7Q53042434-1DEDEBEF-447F-4ED9-8D29-178C19B49432Q54974754-BA1BC8B8-21D4-4551-A946-2E40D24A24E1Q55709480-6CA00E41-E9BF-4441-8F9F-C850D99494D0
P2860
Prospective evaluation of 3-T MRI performed before initial transrectal ultrasound-guided prostate biopsy in patients with high prostate-specific antigen and no previous biopsy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Prospective evaluation of 3-T ...... ntigen and no previous biopsy.
@en
type
label
Prospective evaluation of 3-T ...... ntigen and no previous biopsy.
@en
prefLabel
Prospective evaluation of 3-T ...... ntigen and no previous biopsy.
@en
P2093
P356
P1476
Prospective evaluation of 3-T ...... antigen and no previous biopsy
@en
P2093
Byong Chang Jeong
Byung Kwan Park
Han Yong Choi
Hyun Moo Lee
Jong Wook Park
Seo Yong Park
Seong Il Seo
Seong Soo Jeon
P304
P356
10.2214/AJR.11.6829
P407
P50
P577
2011-11-01T00:00:00Z